Speakers
![](/-/media/project/precisiononcology/precisiononcology/images/news-and-events/speakers/jenniferracz.jpg?h=80&iar=0&w=80&rev=fe60fe4573ef40f28b2d32532205ffa7&hash=8B63509EDB3EF689131BAD97A956E25D)
Director, Medical Affairs, Precision Oncology
![](/-/media/project/precisiononcology/precisiononcology/images/news-and-events/speakers/christy-russell-11-2023.jpg?h=80&iar=0&w=80&rev=7d9b666996b542f4ae1d538b46040bc9&hash=C3070E5F59655F98C649B3F20F7D5952)
Vice President, US Medical Affairs, Precision Oncology
![](/-/media/project/precisiononcology/precisiononcology/images/news-and-events/speakers/jay-andersen.jpg?h=80&iar=0&w=80&rev=79910ff056f44abd85c76a785330061a&hash=3CFB94B88A7C22CB3EF1EFA6B81E4404)
Co-Director, Compass Breast Specialists, Associate Chair, US Oncology Breast Cancer Research Committee
Click on abstract number to see the poster presented at SABCS 2023.
Oncotype DX Data
Update of RSClin® with extended TAILORx follow-up and development and validation of a new tool for risk of late distant recurrence
PO1-02-02 | Sparano
Concordance analysis of paired breast cancer core needle biopsies and surgical excision samples using the Oncotype DX Breast Recurrence Score® assay
PO4-08-09 | Nassar
Magnetic Resonance Imaging and a 12-Gene Expression Assay to Optimize Local Therapy for Ductal Carcinoma In Situ: 5-year clinical outcomes of E4112
GS03-01 | Khan
Impact of age and ovarian function suppression (OFS) on endocrine response to short preoperative endocrine therapy (ET): Results from the multicenter ADAPTcycle trial (n=4,334).
LBO1-05 | Gluz
OncoExTra Data
Comparison of whole exome, whole transcriptome genomic profiling and targeted sequencing with 50-gene panels
PO5-13-05 | Thakkar
Classifying HER2-low breast cancer using a combination of ERBB2 mRNA expression and altered genes
PO5-13-06 | Basu
Prevalence of genomic alterations in Xerna tumor microenvironment subtypes in triple negative breast cancer patients
PO5-13-10 | Basu
PreventionGenetics Data
Cox: Hereditary cancer genetic testing in Puerto Rican females
PO1-08-08 | Cox
Director, Medical Affairs, Precision Oncology
Vice President, US Medical Affairs, Precision Oncology
Co-Director, Compass Breast Specialists, Associate Chair, US Oncology Breast Cancer Research Committee